Optimization of an automated DNA purification protocol for neonatal screening

Archives of Pathology and Laboratory Medicine

Volumn 123, Issue 12, 1999, Pages 1154-1160

  Heath, Ellen M ^a   O'Brien, Darin P ^a   Banas, Richard ^b   Naylor, Edwin W ^b   Dobrowolski, Steven ^b  

^a Gentra Systems Inc   (United States)

^b Neo Gen Screening Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HEME;

ARTICLE; BLOOD SAMPLING; DNA DETERMINATION; DNA PURIFICATION; GENE AMPLIFICATION; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LABORATORY AUTOMATION; NEWBORN SCREENING; PROTEIN PROCESSING;

EID: 0032761938     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. McCabe ERB, Huang SZ, Seltzer WK, Law ML. DNA microextraction from dried blood spots on filter paper blotters: potential applications to newborn screening. Hum Genet. 1987;75:213-216.
2. McCabe ERB. Utility of PCR for DNA analysis from dried blood spots on filter paper blotters. PCR Meth Appl. 1991;1:99-106.
3. Feder JN, Gnirke A, Thomas W, et al. A novel MHC Class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399-408.
4. Morel P, Dorman J, Todd J, McDevitt H, Trucco M. Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study. Proc Natl Acad Sci U S A. 1988;85:8111-8115.
5. She JX. Susceptibility to type I diabetes: HLA-DQ and -DR revisited. Hum Immunol. 1996;17:323-332.